BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31768620)

  • 1. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.
    Kommoss FKF; Stichel D; Schrimpf D; Kriegsmann M; Tessier-Cloutier B; Talhouk A; McAlpine JN; Chang KTE; Sturm D; Pfister SM; Romero-Pérez L; Kirchner T; Grünewald TGP; Buslei R; Sinn HP; Mechtersheimer G; Schirmacher P; Schmidt D; Lehr HA; Sahm F; Huntsman DG; Gilks CB; Kommoss F; von Deimling A; Koelsche C
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):97-104. PubMed ID: 31768620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.
    Kommoss FK; Chang KT; Stichel D; Banito A; Jones DT; Heilig CE; Fröhling S; Sahm F; Stenzinger A; Hartmann W; Mechtersheimer G; Sinn HP; Schmidt D; Kommoss F; von Deimling A; Koelsche C
    J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
    Alkanat NE; Uner A; Usubutun A
    Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
    [No Abstract]   [Full Text] [Related]  

  • 4. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
    Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
    Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
    Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
    Chiang S; Vasudevaraja V; Serrano J; Stewart CJR; Oliva E; Momeni-Boroujeni A; Jungbluth AA; Da Cruz Paula A; da Silva EM; Weigelt B; Park KJ; Soslow RA; Murali R; Ellenson LH; Benayed R; Ladanyi M; Abu-Rustum NR; Dickson MA; Cohen S; Aghajanian C; Hensley ML; Lee CH; Snuderl M; Konner JA
    Mod Pathol; 2022 Jan; 35(1):117-127. PubMed ID: 34561551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].
    Lax SF
    Pathologe; 2019 Feb; 40(1):36-45. PubMed ID: 30694356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
    Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
    Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Uterine Mesenchymal Neoplasms.
    Kertowidjojo EC; Bennett JA
    Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.
    Lee CH; Kao YC; Lee WR; Hsiao YW; Lu TP; Chu CY; Lin YJ; Huang HY; Hsieh TH; Liu YR; Liang CW; Chen TW; Yip S; Lum A; Kuo KT; Jeng YM; Yu SC; Chung YC; Lee JC
    Am J Surg Pathol; 2019 Jul; 43(7):928-942. PubMed ID: 31094921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.
    Oliva E; Clement PB; Young RH
    Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine tumors resembling ovarian sex cord tumors: an update.
    Czernobilsky B
    Int J Gynecol Pathol; 2008 Apr; 27(2):229-35. PubMed ID: 18317219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of
    Verma A; Menon S; Rekhi B; Pai T; Maheshwari A; Ghosh J; Gupta S; Deodhar K
    Indian J Cancer; 2019; 56(4):335-340. PubMed ID: 31607703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.
    Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N
    Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological study of BCOR rearrangement in high grade endometrial stromal sarcoma].
    Cheng YF; Bai QM; Bi R; Chang B; Huang D; Yu L; Zhou XY; Yang WT; Tu XY
    Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):604-609. PubMed ID: 31422590
    [No Abstract]   [Full Text] [Related]  

  • 17. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With
    Ling F; Ruan S; Chen H; Xiong X; Zhao D; Haybaeck J; Zhang C
    In Vivo; 2022; 36(4):1971-1976. PubMed ID: 35738637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.
    Busca A; Gulavita P; Parra-Herran C; Islam S
    Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus.
    Wang L; Felix JC; Lee JL; Tan PY; Tourgeman DE; O'Meara AT; Amezcua CA
    Gynecol Oncol; 2003 Aug; 90(2):402-6. PubMed ID: 12893208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.